InsiderTrades

Form 4 for IMDX Insight Molecular Diagnostics Inc.

Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001493152-22-023376 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-08-17 2022-08-16 IMDX Carter Jennifer L. Dir P - Purchase $0.95 +10.5K 30.5K +52% +$9,975
D 2022-08-17 2022-08-15 IMDX Carter Jennifer L. Dir A - Grant $0.00 +10.0K 20.0K +100% $0
D 2022-08-17 2022-08-15 IMDX Carter Jennifer L. Dir A - Grant $0.00 +45.0K 45.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, no par value 2022-08-16 P A 10,500 $0.95 30,500 D — —
2 Common Common Stock, no par value 2022-08-15 A A 10,000 $0.00 20,000 D — — (F1) The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
3 Derivative Option to Purchase Common Stock 2022-08-15 A A 45,000 $0.00 45,000 D $0.97 · — to 2032-08-15 45,000 Common Stock (F2) Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.